- Home
- ALDX vs BRY Comparison
ALDX vs BRY Comparison
Compare ALDX & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BRY
- Stock Information
- Founded
- ALDX 2004
- BRY 1909
- Country
- ALDX United States
- BRY United States
- Employees
- ALDX N/A
- BRY N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- ALDX Health Care
- BRY Energy
- Exchange
- ALDX Nasdaq
- BRY Nasdaq
- Market Cap
- ALDX 160.8M
- BRY 186.1M
- IPO Year
- ALDX 2014
- BRY N/A
- Fundamental
- Price
- ALDX $5.01
- BRY $3.10
- Analyst Decision
- ALDX Strong Buy
- BRY Buy
- Analyst Count
- ALDX 2
- BRY 2
- Target Price
- ALDX $9.50
- BRY $5.00
- AVG Volume (30 Days)
- ALDX 1.2M
- BRY 1.2M
- Earning Date
- ALDX 07-31-2025
- BRY 08-08-2025
- Dividend Yield
- ALDX N/A
- BRY 3.87%
- EPS Growth
- ALDX N/A
- BRY N/A
- EPS
- ALDX N/A
- BRY N/A
- Revenue
- ALDX N/A
- BRY $753,737,000.00
- Revenue This Year
- ALDX N/A
- BRY N/A
- Revenue Next Year
- ALDX N/A
- BRY $1.01
- P/E Ratio
- ALDX N/A
- BRY N/A
- Revenue Growth
- ALDX N/A
- BRY N/A
- 52 Week Low
- ALDX $1.14
- BRY $2.11
- 52 Week High
- ALDX $7.20
- BRY $7.02
- Technical
- Relative Strength Index (RSI)
- ALDX 81.79
- BRY 53.89
- Support Level
- ALDX $4.12
- BRY $3.13
- Resistance Level
- ALDX $4.92
- BRY $3.12
- Average True Range (ATR)
- ALDX 0.33
- BRY 0.17
- MACD
- ALDX 0.10
- BRY 0.01
- Stochastic Oscillator
- ALDX 98.53
- BRY 62.50
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.